MicroRNA 223 is up-regulated in the multistep progression of Barrett’s esophagus and modulates sensitivity to chemotherapy by targeting PARP1 [30], it also modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells [31]. Here, PARP1 is linked to hepatocellular carcinoma.